Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Japanese Journal of Ophthalmology
Published in: Japanese Journal of Ophthalmology 4/2017

01-07-2017 | Clinical Investigation

Annual incidences of visual impairment during 10-year period in Mie prefecture, Japan

Authors: Kengo Ikesugi, Takako Ichio, Hideyuki Tsukitome, Mineo Kondo

Published in: Japanese Journal of Ophthalmology | Issue 4/2017

Login to get access

Abstract

Purpose

To determine the annual incidence of visual impairment in a Japanese population during a 10-year period.

Methods

We examined the physical disability certificates issued yearly between 2004 and 2013 in Mie prefecture, Japan. During this period 2468 visually impaired people were registered under the newly defined Act on Welfare of the Physically Disabled Persons’ criteria. The age, sex distribution, and causes of visual impairment were determined from the certificates.

Results

The major causes of visual impairment during the ten-year period were glaucoma (23.3%), diabetic retinopathy (17.3%), retinitis pigmentosa (12.2%), macular degeneration (9.0%), chorioretinal degeneration or high myopia (7.4%), optic atrophy (5.8%), stroke or brain tumor (5.4%) and cataracts (3.7%). The incidence of glaucoma was significantly higher throughout the period (2004–2013), and that of diabetic retinopathy was lower between 2007 and 2013. The incidence of retinitis pigmentosa did not change significantly during the 10-year period. The incidence of macular degeneration tended to increase between 2004 and 2007, but it decreased significantly between 2007 and 2013.

Conclusions

The results indicate that in Japan, the rates of the major causes of visual impairment altered in the most recent 10-year period reflecting the recent changes in the social background and advances in ocular and systemic treatment.
Literature
1.
Xu L, Wang Y, Li Y, Wang Y, Cui T, Li J, et al. Causes of blindness and visual impairment in urban and rural areas in Beijing: the Beijing Eye Study. Ophthalmology. 2006;113:1134.e1–11.PubMed
2.
Zheng Y, Lavanya R, Wu R, Wong WL, Wang JJ, Mitchell P, et al. Prevalence and causes of visual impairment and blindness in an urban Indian population: the Singapore Indian Eye Study. Ophthalmology. 2011;118:1798–804.CrossRefPubMed
3.
Hennis AJ, Wu SY, Nemesure B, Hyman L, Schachat AP, Leske MC. Nine-year incidence of visual impairment in the Barbados Eye Studies. Ophthalmology. 2009;116:1461–8.CrossRefPubMedPubMedCentral
4.
Stevens GA, White RA, Flaxman SR, Price H, Jonas JB, Keeffe J, et al. Global prevalence of vision impairment and blindness: magnitude and temporal trends, 1990–2010. Ophthalmology. 2013;120:2377–84.CrossRefPubMed
5.
Nakae K, Kogure F, Nagaya Y, Mishima S. Wagakuniniokeru shikakusyogai no genkyo. J Health Welf Stat (Kousei no Shihyo). 1991;38:13–22.
6.
Nakae K, Masuda K, Ishibashi T. Recent causes of visual disturbances in Japan—comparison with causes 15 years ago. J Clin Exp Med (Igaku no Ayumi). 2008;225:691–3.
7.
Wako R, Yasukawa T, Kato A, Omori T, Ishida S, Ishibashi T, et al. Causes and prevalence of visual impairment in Japan. Nippon Ganka Gakkai Zasshi. 2014;118:495–501.PubMed
8.
Ikesugi K, Tsukitome H, Yagi T, Yamaguchi T, Tamei I, Sasoh M, et al. Causes of visual impairment in Mie prefecture during a 5-year period. Nippon Ganka Gakkai Zasshi. 2010;114:505–11.PubMed
9.
Ikesugi K, Sasoh M, Uji Y. Causes of visual impairment in those below 40 years of age. J Eye (Atarashii Ganka). 2011;28:743–6 (in Japanese).
10.
Tielsch JM, Sommer A, Katz J, Royall RM, Quigley HA, Javitt J. Racial variations in the prevalence of primary open-angle glaucoma. The baltimore eye survey. JAMA. 1991;266:369–74.CrossRefPubMed
11.
Iwase A, Suzuki Y, Araie M, Yamamoto T, Abe H, Shirato S, et al. The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. Ophthalmology. 2004;111:1641–8.PubMed
12.
Yamamoto S, Sawaguchi S, Iwase A, Yamamoto T, Abe H, Tomita G, et al. Primary open-angle glaucoma in a population associated with high prevalence of primary angle-closure glaucoma: the Kumejima Study. Ophthalmology. 2014;121:1558–65.CrossRefPubMed
13.
Salomon JA, Wang H, Freeman MK, Vos T, Flaxman AD, Lopez AD, et al. Healthy life expectancy for 187 countries, 1990-2010: a systematic analysis for the Global Burden Disease Study 2010. Lancet. 2012;380:2144–62.CrossRefPubMed
14.
15.
16.
Schmidt-Erfurth U, Lang GE, Holz FG, Schlingemann RO, Lanzetta P, Massin P, et al. Three-year outcomes of individualized ranibizumab treatment in patients with diabetic macular edema: the RESTORE extension study. Ophthalmology. 2014;121:1045–53.CrossRefPubMed
17.
Heier JS, Bressler NM, Avery RL, Bakri SJ, Boyer DS, Brown DM, et al. Comparison of aflibercept, bevacizumab, and ranibizumab for treatment of diabetic macular edema: extrapolation of data to clinical practice. JAMA Ophthalmol. 2016;134:95–9.CrossRefPubMed
18.
Farouk MM, Naito T, Sayed KM, Nagasawa T, Katome T, Radwan G, et al. Outcomes of 25-gauge vitrectomy for proliferative diabetic retinopathy. Graefe’s Arch Clin Exp Ophthalmol. 2011;249:369–76.CrossRef
19.
Guthrie G, Magill H, Steel DH. 23-gauge versus 25-gauge vitrectomy for proliferative diabetic retinopathy: a comparison of surgical outcomes. Ophthalmologica. 2015;233:104–11.CrossRefPubMed
20.
Neville SE, Boye KS, Montgomery WS, Iwamoto K, Okamura M, Hayes RP. Diabetes in Japan: a review of disease burden and approaches to treatment. Diabetes/Metab Res Rev. 2009;25:705–16.CrossRef
21.
Iwase A, Araie M, Tomidokoro A, Yamamoto T, Shimizu H, Kitazawa Y, et al. Prevalence and causes of low vision and blindness in a Japanese adult population: the Tajimi study. Ophthalmology. 2006;113:1354–62.CrossRefPubMed
22.
Yamada M, Hiratsuka Y, Roberts CB, Pezzullo ML, Yates K, Takano S, et al. Prevalence of visual impairment in the adult Japanese population by cause and severity and future projections. Ophthalmic Epidemiol. 2010;17:50–7.CrossRefPubMed
23.
24.
Rowland TJ, Buchholz DE, Clegg DO. Pluripotent human stem cells for the treatment of retinal disease. J Cell Physiol. 2012;227:457–66.CrossRefPubMed
25.
Ramsden CM, Powner MB, Carr AJ, Smart MJ, da Cruz L, Coffey PJ. Stem cells in retinal regeneration: past, present and future. Development. 2013;140:2576–85.CrossRefPubMedPubMedCentral
26.
Bassuk AG, Zheng A, Li Y, Tsang SH, Mahajan VB. Precision medicine: genetic repair of retinitis pigmentosa in patient-derived stem cells. Sci Rep. 2016;6:19969.CrossRefPubMedPubMedCentral
27.
Luo YH, da Cruz L. The argus((R)) II retinal prosthesis system. Prog Retinal Eye Res. 2016;50:89–107.CrossRef
28.
Chow AY, Bittner AK, Pardue MT. The artificial silicon retina in retinitis pigmentosa patients (an American Ophthalmological Association thesis). Trans Am Ophthalmol Soc. 2010;108:120–54.PubMedPubMedCentral
29.
Bourne RR, Jonas JB, Flaxman SR, Keeffe J, Leasher J, Naidoo K, et al. Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe: 1990–2010. Br J Ophthalmol. 2014;98:629–38.CrossRefPubMed
30.
Bloch SB, Larsen M, Munch IC. Incidence of legal blindness from age-related macular degeneration in denmark: year 2000 to 2010. Am J Ophthalmol. 2012;153(209–13):e2.
31.
32.
Tanito M, Miyake T, Ohira A. The rate of official registration of legally visually handicapped patients in the handbook of the physically handicapped. Atarashii Ganka (Journal of the Eye). 2000;17:1315–8.
33.
Hotta K, Sasho A. Shikakusyogaisya ni yoru Shintaisyogaisyatecyosyutoku no Genjyo to Kadai. Nihon no Ganka (Ophthalmic practice). 2003;74:1021–3.
34.
Fujita A, Saito K, Ando N, Ogawa I, Abe H. Current status of registration as visually handicapped by outpatients in Niigata Prefecture. Rinsho Ganka (Jpn J Clin Ophthalmol). 1999;53:725728.
35.
Nakamura Y, Tomidokoro A, Sawaguchi S, Sakai H, Iwase A, Araie M. Prevalence and causes of low vision and blindness in a rural Southwest Island of Japan: the Kumejima study. Ophthalmology. 2010;117:2315–21.CrossRefPubMed
Metadata
Title
Annual incidences of visual impairment during 10-year period in Mie prefecture, Japan
Authors
Kengo Ikesugi
Takako Ichio
Hideyuki Tsukitome
Mineo Kondo
Publication date
01-07-2017
Publisher
Springer Japan
Published in
Japanese Journal of Ophthalmology / Issue 4/2017
Print ISSN: 0021-5155
Electronic ISSN: 1613-2246
DOI
https://doi.org/10.1007/s10384-017-0517-x

Other articles of this Issue 4/2017

Japanese Journal of Ophthalmology 4/2017 Go to the issue

Clinical Investigation

Patterns of glaucoma progression in retinal nerve fiber and macular ganglion cell-inner plexiform layer in spectral-domain optical coherence tomography

Clinical Investigation

Evaluation of kinetic programs in various automated perimeters

Clinical Investigation

The relationship between vascular endothelial dysfunction and treatment frequency in neovascular age-related macular degeneration

Clinical Investigation

Effect of glaucoma implant surgery on intraocular pressure reduction, flare count, anterior chamber depth, and corneal endothelium in primary open-angle glaucoma

Clinical Investigation

Immunophenotypic profiles for distinguishing orbital mucosa-associated lymphoid tissue lymphoma from benign lymphoproliferative tumors

Clinical Investigation

Upper fornix approach combined with a superior lateral cantholysis: a minimally invasive approach to the superonasal intraconal space